🏠 Study Hub 🖼️ Infographics
Nursing Field Notes / Musculoskeletal ยท Pharmacology Course

Muscle Relaxers ๐ŸŽฏ

Top Tips โ€” Drug-by-Drug NCLEX Quick Reference

NG-156 MUSCULOSKELETAL ยท PHARM ADHD-friendly visual edition

This page is the quick-reference companion โ€” one snapshot card per named drug with its own memory trick, plus the traps NCLEX loves. For class-wide mechanism (central vs peripheral), general contraindications, interactions & the sedation/fall-risk safety rule, see NG-155 (Muscle Relaxants) โ€” not repeated here.

โ†’ Open NG-155: Muscle Relaxants (class overview + mechanism)

📄 Simple Nursing original — opens in Drive →

๐Ÿ”ฅ DantroleneMH treatment + spasticity ยท direct muscle action ยท watch the liver.
๐Ÿ˜ต CyclobenzaprineTCA look-alike ยท anticholinergic effects ยท short-term only.
๐Ÿšซ BaclofenGABA-B agonist ยท never stop abruptly โ€” rebound spasticity/seizures.
๐Ÿ”’ CarisoprodolControlled substance ยท metabolized to meprobamate ยท abuse potential.
๐Ÿ—‚๏ธ

SNAPSHOTS

STEP 1 ยท MEET THE DRUGS

Four named drugs, four separate personalities โ€” one memory hook each.

๐Ÿ”ฅ Dantrolene โ€” the muscle-fiber blocker

SKELETAL MUSCLE FIBER ๐Ÿšซ Caยฒโบ MOA: blocks calcium release from the sarcoplasmic reticulum = less Caยฒโบ = less contraction the ONE relaxant that works directly on muscle

Used for:

  • ๐ŸŒก๏ธ Malignant hyperthermia โ€” acute IV treatment
  • ๐Ÿงฉ Chronic spasticity: spinal cord injury, cerebral palsy, multiple sclerosis

Watch for:

  • ๐Ÿ˜ด Sedation / drowsiness
  • ๐Ÿงช Hepatotoxicity โ€” monitor liver function
  • โŒ Contraindicated: active hepatic disease, lactation, spasm from rheumatic disorders
๐Ÿง  "Calcium CONTRACTS, dantrolene BLOCKS." Less calcium release = less contraction. And: Dantrolene = treats the FIRE (malignant hyperthermia) but can BURN the liver โ€” check LFTs.

๐Ÿ˜ต Cyclobenzaprine โ€” the TCA look-alike

Body โ€” anti- cholinergic effects ๐Ÿ‘๏ธ Blurred vision ๐Ÿ‘„ Dry mouth ๐Ÿ’“ Tachycardia ๐Ÿšฝ Urinary retention

Used for: acute muscle spasm โ€” short-term only (max 2โ€“3 weeks).

Watch for:

  • ๐Ÿ˜ด Sedation, anticholinergic effects (structurally similar to tricyclic antidepressants)
  • โŒ Contraindicated: recent MI, cardiac conduction disorders, hyperthyroidism
  • โŒ Within 14 days of an MAOI โ€” risk of high fever & convulsions
๐Ÿง  "CycloBACKzzaprine" โ€” relaxes the back, but makes you zzz's. And: it's a cousin of TCAs โ€” so it inherits the classic anticholinergic list ("can't see, can't spit, can't pee, can't poop") plus the cardiac cautions TCAs carry.

๐Ÿšซ Baclofen โ€” GABA-B agonist, never stop abruptly

Stop baclofen: taper vs abrupt โœ… tapered ๐Ÿšจ rebound spike time after last scheduled dose โ†’ spasticity/seizure risk

MOA: enhances GABA (an inhibitory neurotransmitter) at GABA-B receptors โ€” "makes everything low & slow."

Used for: decreased flexor/extensor spasticity โ€” spinal cord injury, MS, cerebral palsy.

Watch for:

  • ๐Ÿ˜ต Orthostatic hypotension, dizziness on position change โ€” expected, not a hold parameter
  • ๐Ÿคข Nausea
  • ๐Ÿšจ Never abruptly stop โ€” rhabdomyolysis, multi-organ failure, seizures, rebound spasticity
  • โŒ Contraindicated: spasm from rheumatic disorders
๐Ÿง  "Baclofen โ€” back off slowly." This is the single highest-yield safety point in the whole muscle relaxant class: taper, never stop cold. Dizziness with position change is expected, not a reason to withhold the dose.

๐Ÿ”’ Carisoprodol โ€” controlled substance, abuse potential

Carisoprodol liver metabolism Meprobamate (active metabolite) = Schedule IV controlled substance sedative + dependence/abuse potential

Used for: acute muscle spasm โ€” e.g., after surgery on open fractures.

Watch for:

  • ๐Ÿ”’ Controlled substance โ€” risk of dependence and abuse
  • ๐Ÿ˜ด Drowsiness & sedation
  • ๐Ÿ›‘ Taper off โ€” do not stop abruptly
  • โŒ Contraindicated: hypersensitivity to meprobamate
๐Ÿง  "Carisoprodol โ†’ meprobamate." The metabolite is itself a controlled sedative-hypnotic โ€” that's exactly why carisoprodol carries abuse potential and is a controlled substance.
๐ŸŽฏ

NCLEX TRAPS

STEP 2 ยท TOP MISSED QUESTIONS

The traps test-writers reuse across this class โ€” spot the pattern, not just the answer.

๐Ÿ“ Missed-question pattern: newly prescribed cyclobenzaprine

A classic SATA stem: "When providing education to a patient newly prescribed cyclobenzaprine, which instructions should be included?" Options mix real teaching with disguised distractors. Practice spotting the pattern rather than memorizing this exact stem:

โœ… Likely correct: Report excessive/unusual drowsiness, especially before driving or hazardous tasks. Do not stop the medication abruptly after regular use. Avoid alcohol entirely.
โŒ Classic distractor: "Limit wine to 3โ€“4 glasses per day" โ€” any answer that quantifies "a little alcohol is fine" is wrong. The real teaching is avoid, not limit.
โŒ Classic distractor: An oddly specific, low fever cutoff (e.g., "notify provider of temp above 99.5ยฐF") โ€” normal fever thresholds you're taught elsewhere are higher; be suspicious of numbers that don't match standard teaching.
๐Ÿง  Trap-spotting rule: "moderation" answers and off-standard numbers are usually wrong. On any CNS-depressant medication question, the safe teaching is almost always the absolute one (avoid, never, do not stop) โ€” not a hedged, permissive version.

๐Ÿšจ Dantrolene dual identity trap

Test writers love testing whether you know dantrolene has two separate uses: emergency IV treatment of malignant hyperthermia AND oral use for chronic spasticity. Don't assume a dantrolene question is automatically about MH โ€” read the scenario.

๐Ÿง  One drug, two hats: ๐Ÿ”ฅ MH = acute IV rescue ยท ๐Ÿงฉ spasticity = chronic oral therapy.

๐Ÿšจ Baclofen "dizziness" trap

A client reports dizziness with position changes on baclofen. This is NOT a reason to withhold the dose or call it a contraindication โ€” orthostatic dizziness is an expected side effect. Teach slow position changes instead.

๐Ÿง  Expected โ‰  emergency. Save your "hold the dose" instinct for abrupt discontinuation, not routine orthostatic dizziness.
๐Ÿ—ฃ๏ธ

QUICK TEACH

STEP 3 ยท ONE-LINERS TO SAY OUT LOUD

One teaching sentence per drug โ€” grab-and-go for clinical or a quick quiz review.

๐Ÿ’ฌ One-liner per drug

DrugSay thisHighest-yield trap
Dantrolene"We'll be checking your liver function while you're on this."Hepatotoxicity monitoring
Cyclobenzaprine"This is short-term โ€” 2 to 3 weeks โ€” and don't mix it with alcohol."TCA-like anticholinergic effects
Baclofen"Never stop this suddenly, even if you feel better โ€” we'll taper it."Rebound spasticity/seizures
Carisoprodol"This is a controlled medication โ€” take exactly as prescribed."Meprobamate metabolite, abuse potential
๐Ÿง  Class-wide add-on for all four: "Expect drowsiness โ€” don't drive until you know how this affects you." That single sentence is correct for every drug on this page.
โ†’ Open NG-155: Muscle Relaxants (full mechanism, contraindications & interactions)
โšก

QUICK RECALL

SAY IT OUT LOUD
๐Ÿ”ฅ DantroleneMH + spasticity ยท direct muscle action ยท watch the liver.
๐Ÿ˜ต CyclobenzaprineTCA cousin ยท anticholinergic ยท short-term only.
๐Ÿšซ BaclofenGABA-B agonist ยท never stop abruptly.
๐Ÿ”’ Carisoprodolโ†’ meprobamate ยท controlled substance.
๐ŸŽฏ Cover & check โ€” 4 rapid-fire questions
Q1: Which two conditions does dantrolene treat, and how do the routes differ?
Malignant hyperthermia (acute IV treatment) and chronic spasticity from spinal cord injury/MS/cerebral palsy (oral). Watch liver function โ€” hepatotoxicity risk.
Q2: Why does cyclobenzaprine carry anticholinergic side effects?
It's structurally related to tricyclic antidepressants (TCAs), so it inherits dry mouth, blurred vision, urinary retention, and tachycardia โ€” plus TCA-style cardiac cautions.
Q3: A client on baclofen wants to stop today because they feel fine. What do you teach?
Never stop abruptly โ€” taper under provider guidance. Sudden discontinuation risks rebound spasticity, seizures, rhabdomyolysis, and multi-organ failure.
Q4: Why is carisoprodol a controlled substance?
It's metabolized in the liver to meprobamate, an active sedative-hypnotic metabolite, giving carisoprodol dependence and abuse potential (Schedule IV).